Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer
Clinical trial NCT02489214 · TERMINATED
Trial details
- NCT number
- NCT02489214
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-16
- Primary completion
- 2019-06-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.